β-Blocker treatment during pregnancy and adverse pregnancy outcomes: A nationwide population-based cohort study

BMJ Open

Volumn 2, Issue 4, 2012, Pages

  Petersen, Kasper Meidahl ^a   Jimenez Solem, Espen ^a   Andersen, Jon Traerup ^a   Petersen, Morten ^a   Brødbæk, Kasper ^a   Køber, Lars ^a   Torp Pedersen, Christian ^b   Poulsen, Henrik Enghusen ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; INSULIN DERIVATIVE; LABETALOL; METHYLDOPA; METOPROLOL; PINDOLOL; PROPRANOLOL; SOTALOL;

ADULT; ADVERSE OUTCOME; ANTIHYPERTENSIVE THERAPY; ARTICLE; COHORT ANALYSIS; DENMARK; ESSENTIAL TREMOR; FEMALE; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MIGRAINE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; OUTCOMES RESEARCH; PERINATAL DEATH; PERINATAL MORTALITY; POPULATION RESEARCH; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRESCRIPTION; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SIDE EFFECT; SMALL FOR DATE INFANT; SOCIOECONOMICS; TREATMENT OUTCOME;

EID: 84864194263     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001185     Document Type: Article

References (26)

1. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335:257-65.
2. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318:1332-6.
3. Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy. Curr Pharm Des 2003;9:1745-53.
4. Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003;(3):CD002863.
5. Lyons KE, Pahwa R. Pharmacotherapy of essential tremor: an overview of existing and upcoming agents. CNS Drugs 2008;22:1037-45.
6. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician 2006;73:72-8.
7. Sibai BM, Gonzalez AR, Mabie WC, et al. Comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol 1987;70:323-7.
8. Magee LA, Elran E, Bull SB, et al. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol 2000;88:15-26.
9. Nakhai-Pour HR, Rey E, Berard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for- gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 2010;89:147-54.
10. Lydakis C, Lip GY, Beevers M, et al. Atenolol and foetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999;12:541-7.
11. Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007;(1):CD002252.
12. Zeitlin J, El AM, Jarreau PH, et al. Impact of foetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010;157:733-9.
13. Challis JR, Lye SJ, Gibb W, et al. Understanding preterm labor. Ann N Y Acad Sci 2001;943:225-34.
14. Knudsen LB. The Danish fertility database. Dan Med Bull 1998;45:221-5.
15. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263e8.
16. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445e8.
17. Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health 2011;39(7 Suppl):103-5.
18. Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health 2011;39(7 Suppl):91-4.
19. Pedersen CB, Gotzsche H, Moller JO, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441e9.
20. Knudsen LB, Børlum Kristensen F. Monitoring perinatal mortality and perinatal care with a national register: content and usage of the Danish Medical Birth Register. Community Med 1986;8:29e36.
21. Karthikeyan VJ, Lip GY. Hypertension in pregnancy: pathophysiology and management strategies. Curr Pharm Des 2007;13:2567e79.
22. Magee LA, Schick B, Donnenfeld AE, et al. The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8.
23. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008;51:960-9.
24. Lennestal R, Otterblad OP, Kallen B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009;65:615e25.
25. World Health Organization. Levels & Trends in Child Mortality. Report 2011. Estimates Developed by the UN Inter-agency for Child Mortality Estimation. World Health Organization, 2011. http://www.who.int/child- adolescent-health/documents/child/childmortality-booklet-2011.pdf. Ref type: online source.
26. Olesen C, Sondergaard C, Thrane N, et al. Do pregnant women report use of dispensed medications? Epidemiology 2001;12:497-501.